Table 1

Hazard ratio for secondary cardiovascular outcomes associated with Lipoprotein(a) ≥ 200 vs. <200 nmol/L

Secondary outcomeUnadjustedAdjusted
HR95% CIP-valueHR95% CIP-value
MI1.41(1.12–1.78)0.0041.40(1.11–1.78)0.005a
Ischaemic stroke1.19(0.83–1.72)0.3361.13(0.77–1.66)0.536b
Coronary revascularization1.40(1.13–1.72)0.0021.42(1.14–1.75)0.001a
CHD death1.40(1.07–1.83)0.0131.52(1.16–2.01)0.003c
CHD death and MI1.31(1.08–1.60)0.0071.35(1.10–1.66)0.004a
CV death1.27(1.02–1.58)0.0291.39(1.10–1.74)0.005a
CV death, MI, and ischaemic stroke1.27(1.07–1.51)0.0051.31(1.09–1.56)0.003a
CV death, MI, ischaemic stroke, and coronary revascularization1.26(1.08–1.47)0.0031.29(1.10–1.51)0.002a
All-cause mortality1.04(0.89–1.22)0.6221.10(0.93–1.30)0.255a
Secondary outcomeUnadjustedAdjusted
HR95% CIP-valueHR95% CIP-value
MI1.41(1.12–1.78)0.0041.40(1.11–1.78)0.005a
Ischaemic stroke1.19(0.83–1.72)0.3361.13(0.77–1.66)0.536b
Coronary revascularization1.40(1.13–1.72)0.0021.42(1.14–1.75)0.001a
CHD death1.40(1.07–1.83)0.0131.52(1.16–2.01)0.003c
CHD death and MI1.31(1.08–1.60)0.0071.35(1.10–1.66)0.004a
CV death1.27(1.02–1.58)0.0291.39(1.10–1.74)0.005a
CV death, MI, and ischaemic stroke1.27(1.07–1.51)0.0051.31(1.09–1.56)0.003a
CV death, MI, ischaemic stroke, and coronary revascularization1.26(1.08–1.47)0.0031.29(1.10–1.51)0.002a
All-cause mortality1.04(0.89–1.22)0.6221.10(0.93–1.30)0.255a

Bold text indicates statistical significance at an alpha level of 0.05.

CI, confidence interval; CHD, coronary heart disease; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction.

a

Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, and smoking.

b

Adjusted for: Age and sex.

c

Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, and chronic kidney disease.

Table 1

Hazard ratio for secondary cardiovascular outcomes associated with Lipoprotein(a) ≥ 200 vs. <200 nmol/L

Secondary outcomeUnadjustedAdjusted
HR95% CIP-valueHR95% CIP-value
MI1.41(1.12–1.78)0.0041.40(1.11–1.78)0.005a
Ischaemic stroke1.19(0.83–1.72)0.3361.13(0.77–1.66)0.536b
Coronary revascularization1.40(1.13–1.72)0.0021.42(1.14–1.75)0.001a
CHD death1.40(1.07–1.83)0.0131.52(1.16–2.01)0.003c
CHD death and MI1.31(1.08–1.60)0.0071.35(1.10–1.66)0.004a
CV death1.27(1.02–1.58)0.0291.39(1.10–1.74)0.005a
CV death, MI, and ischaemic stroke1.27(1.07–1.51)0.0051.31(1.09–1.56)0.003a
CV death, MI, ischaemic stroke, and coronary revascularization1.26(1.08–1.47)0.0031.29(1.10–1.51)0.002a
All-cause mortality1.04(0.89–1.22)0.6221.10(0.93–1.30)0.255a
Secondary outcomeUnadjustedAdjusted
HR95% CIP-valueHR95% CIP-value
MI1.41(1.12–1.78)0.0041.40(1.11–1.78)0.005a
Ischaemic stroke1.19(0.83–1.72)0.3361.13(0.77–1.66)0.536b
Coronary revascularization1.40(1.13–1.72)0.0021.42(1.14–1.75)0.001a
CHD death1.40(1.07–1.83)0.0131.52(1.16–2.01)0.003c
CHD death and MI1.31(1.08–1.60)0.0071.35(1.10–1.66)0.004a
CV death1.27(1.02–1.58)0.0291.39(1.10–1.74)0.005a
CV death, MI, and ischaemic stroke1.27(1.07–1.51)0.0051.31(1.09–1.56)0.003a
CV death, MI, ischaemic stroke, and coronary revascularization1.26(1.08–1.47)0.0031.29(1.10–1.51)0.002a
All-cause mortality1.04(0.89–1.22)0.6221.10(0.93–1.30)0.255a

Bold text indicates statistical significance at an alpha level of 0.05.

CI, confidence interval; CHD, coronary heart disease; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction.

a

Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, chronic kidney disease, and smoking.

b

Adjusted for: Age and sex.

c

Adjusted for: Age, sex, hypertension, hyperlipidaemia, diabetes mellitus, and chronic kidney disease.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close